JACOBS LEVY EQUITY MANAGEMENT, INC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in PMVP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$94,475

-$128,567 QoQ

Shares Held

70,504

-60.8% QoQ

Ownership

0.132%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 64 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. PMVP ranks #78 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$94,475	70,504	-60.8%	Shares	Sole	2026-08-14
2026-03-31	$223,042	179,873	-65.7%	Shares	Sole	2026-05-15
2025-12-31	$655,437	524,350	+663.6%	Shares	Sole	2026-02-13
2025-09-30	$96,135	68,668	-47.1%	Shares	Sole	2025-11-17
2025-03-31	$141,606	129,914	-75.9%	Shares	Sole	2025-05-15
2024-12-31	$815,238	539,893	-23.5%	Shares	Sole	2025-02-14
2024-09-30	$1,051,333	705,593	-9.4%	Shares	Sole	2024-11-14
2024-06-30	$1,262,020	779,025	-5.8%	Shares	Sole	2024-08-14
2024-03-31	$1,405,396	826,704	+92.4%	Shares	Sole	2024-05-15
2023-12-31	$1,331,890	429,642	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.